Release of Task Force Report; Guidance for Industry and FDA: Interim Evidence-Based Ranking System for Scientific Data; Withdrawal of Guidance, 3060-3061 [E9-959]
Download as PDF
3060
Federal Register / Vol. 74, No. 11 / Friday, January 16, 2009 / Notices
Budget (OMB) under the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501–
3520). The collections of information in
21 CFR 101.14 and 101.70 have been
approved under OMB control no. 0910–
0381.
III. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) written or electronic
comments regarding this document.
Submit a single copy of electronic
comments or two paper copies of any
mailed comments, except that
individuals may submit one paper copy.
Comments are to be identified with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
IV. Electronic Access
Persons with access to the Internet
may obtain the guidance at https://
www.cfsan.fda.gov/guidance.html.
mstockstill on PROD1PC66 with NOTICES
V. References
The following references have been
placed on display in the Division of
Dockets Management (see ADDRESSES)
and may be seen by interested persons
between 9 a.m. and 4 p.m., Monday
through Friday. (FDA has verified the
Web site address, but FDA is not
responsible for any subsequent changes
to this Web site after this document
publishes in the Federal Register.)
1. American Cancer Society, Cancer Facts
and Figures, 2004.
2. The Alpha-Tocopherol, Beta Carotene
Cancer Prevention Study Group, ‘‘The Effect
of Vitamin E and Beta Carotene on the
Incidence of Lung Cancer and Other Cancers
in Male Smokers, New England Journal of
Medicine, 330:1029–1035, 1994.
3. Barton S., ‘‘Which Clinical Studies
Provide the Best Evidence? The Best RCT
Still Trumps the Best Observational Study,’’
British Medical Journal, 321:255–256, 2000.
4. Cade, J., R. Thompson, V. Burley, et al.,
‘‘Development, Validation and Utilization of
Food-Frequency Questionnaires—A Review,
Public Health Nutrition, 5:567–587, 2002.
5. Federal Judicial Center, Reference
Manual on Scientific Evidence, 2d ed., 2000.
6. Flegal K.M., ‘‘Evaluating
Epidemiological Evidence of the Effects of
Food and Nutrient Exposures,’’ American
Journal of Clinical Nutrition, 69:1339S–
1344S, 1999.
7. Greer N., G. Mosser, G. Logan, et al., ‘‘A
Practical Approach to Evidence Grading,’’
Joint Commission Journal on Quality
Improvements, 26:700–712, 2000.
8. Hill A.B., ‘‘The Environment and
Disease: Association or Causation?,’’
Proceedings of the Royal Society of Medicine,
58:295–300, 1965.
9. Hord N.G. and J.I. Fenton, ‘‘Context is
Everything: Mining the Normal and
VerDate Nov<24>2008
19:02 Jan 15, 2009
Jkt 217001
Preneoplastic Microenvironment for Insights
Into the Diet and Cancer Risk Conundrum,’’
Molecular Nutrition and Food Research,
51:100–106, 2007.
10. IOM, Institute of Medicine, ‘‘Dietary
Supplements: A Framework for Evaluating
Safety,’’ National Academies Press,
Washington, DC, 2005.
11. Kraemer H.C., K.K. Lowe, D.J. Kupfer,
To Your Health: How to Understand What
Research Tell Us About Risk, Oxford
University Press, 2005.
12. Kris-Etherton, P.M. and J. Dietschy,
‘‘Design Criteria for Studies Examining
Individual Fatty Acid Effects on
Cardiovascular Disease Risk Factors: Human
and Animal Studies,’’ American Journal of
Clinical Nutrition, 1590S–1596S, 1997.
13. Lichtenstein, A.H. and R.M. Russell,
‘‘Essential Nutrients: Food or Supplements?’’
Journal of American Medical Association,
294:351–358, 2005.
14. Milner J.A., ‘‘Diet and Cancer: Facts
and Controversies,’’ Nutrition and Cancer,
56: 216–224, 2006.
15. National Cancer Institute, Dictionary of
Cancer Terms, https://www.cancer.gov/
dictionary.
16. National Research Council, ‘‘Diet and
Health: Implications for Reducing Chronic
Disease Risk,’’ National Academy Press,
Washington, DC, 1989.
17. Omenn, G.S., G.E. Goodman, M.D.
Thornquist, et al., ‘‘Effects of a Combination
of Beta Carotene and Vitamin A on Lung
Cancer and Cardiovascular Disease,’’ New
England Journal of Medicine, 334:1150–1155,
1996.
18. Peto, R., R. Doll, J.D. Buckley, et al.,
‘‘Can Dietary Beta-Carotene Materially
Reduce Human Cancer Rates?,’’ Nature,
290:201–208, 1981.
19. Sempos C.T., K. Liu, N.D. Earnst,
‘‘Food and Nutrient Exposures: What to
Consider When Evaluating Epidemiologic
Data,’’ American Journal of Clinical
Nutrition, 69:1330S–1338S, 1999.
20. Torun B., ‘‘Protein-Energy
Malnutrition,’’ In: Modern Nutrition in
Health and Disease, Williams and Williams,
New York, 2006.
21. Spilker, B., Guide to Clinical Studies,
Raven Press, New York, 1991.
22. Subar, A., et al., ‘‘Comparative
Validation of the Block, Willett, and National
Cancer Institute Food Frequency
Questionnaires,’’ American Journal of
Epidemiology, 154:1089–1099, 2001.
23. Szklo M. and F.J. Nieto, Epidemiology
Beyond the Basics, Aspen Publishing, 2000.
24. Willett, W.C., ‘‘Overview of Nutritional
Epidemiology,’’ Nutritional Epidemiology,
Oxford University Press, Oxford, 1990.
25. Willett, W.C., ‘‘Issues in Analysis and
Presentation of Dietary Data,’’ In Nutritional
Epidemiology, 2d ed., Oxford University
Press, Oxford, 1998.
26. Wilson, E.B., ‘‘An Introduction to
Scientific Research,’’ General Publishing Co.,
Toronto, 1990.
Dated: January 13, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E9–957 Filed 1–15–09; 8:45 am]
BILLING CODE 4160–01–S
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–1999–D–0170] (formerly
Docket No. 1999D–5424)
Guidance for Industry: Significant
Scientific Agreement in the Review of
Health Claims for Conventional Foods
and Dietary Supplements; Withdrawal
of Guidance
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; withdrawal.
SUMMARY: The Food and Drug
Administration (FDA) is announcing the
withdrawal of a guidance entitled
‘‘Guidance for Industry: Significant
Scientific Agreement in the Review of
Health Claims for Conventional Foods
and Dietary Supplements,’’ that was
issued December 1999.
DATES: The withdrawal is effective
January 16, 2009.
FOR FURTHER INFORMATION CONTACT:
Paula R. Trumbo, Center for Food Safety
and Applied Nutrition (HFS–830), Food
and Drug Administration, 5100 Paint
Branch Pkwy., College Park, MD, 20740,
301–436–2579.
SUPPLEMENTARY INFORMATION: In a notice
published in the Federal Register of
December 22, 1999 (64 FR 71794), FDA
announced the availability of a guidance
entitled ‘‘Guidance for Industry:
Significant Scientific Agreement in the
Review of Health Claims for
Conventional Foods and Dietary
Supplements.’’ This guidance is being
withdrawn because it is obsolete.
Dated: January 13, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E9–964 Filed 1–15–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2003–N–0103] (formerly
Docket No. 2003N–0069)
Release of Task Force Report;
Guidance for Industry and FDA:
Interim Evidence-Based Ranking
System for Scientific Data; Withdrawal
of Guidance
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
E:\FR\FM\16JAN1.SGM
Notice; withdrawal.
16JAN1
3061
Federal Register / Vol. 74, No. 11 / Friday, January 16, 2009 / Notices
SUMMARY: The Food and Drug
Administration (FDA) is announcing the
withdrawal of the guidance entitled
‘‘Guidance for Industry and FDA:
Interim Evidence-Based Ranking System
for Scientific Data’’ that was issued on
July 10, 2003.
DATES: The withdrawal is effective
January 16, 2009.
FOR FURTHER INFORMATION CONTACT:
Paula R. Trumbo, Center for Food Safety
and Applied Nutrition (HFS–830), Food
and Drug Administration, 5100 Paint
Branch Pkwy., College Park, MD, 20740,
301–436–2579.
SUPPLEMENTARY INFORMATION: In a notice
published in the Federal Register of
July 11, 2003 (68 FR 41387), FDA
announced the availability of a guidance
entitled ‘‘Guidance for Industry and
FDA: Interim Evidence-Based Ranking
System for Scientific Data.’’ This
guidance is being withdrawn because it
is obsolete.
Dated: January 13, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E9–959 Filed 1–15–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection:
Comment Request
In compliance with the requirement
for opportunity for public comment on
proposed data collection projects
(section 3506(c)(2)(A) of Title 44, United
States Code, as amended by the
Paperwork Reduction Act of 1995,
Public Law 104–13), the Health
Resources and Services Administration
(HRSA) publishes periodic summaries
of proposed projects being developed
for submission to OMB under the
Paperwork Reduction Act of 1995. To
request more information on the
proposed project or to obtain a copy of
the data collection plans and draft
instruments, e-mail
paperwork@hrsa.gov or call the HRSA
Reports Clearance Officer on (301) 443–
1129.
Comments are invited on: (a) The
proposed collection of information for
the proper performance of the functions
of the agency; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology.
Proposed Project: Uncompensated
Services Assurance Report (OMB No.
0915–0077)—Extension
Under the Hill-Burton Act, the
Government provides grants and loans
for construction or renovation of health
care facilities. As a condition of
receiving this construction assistance,
facilities are required to provide
services to persons unable to pay. A
condition of receiving this assistance
requires facilities to provide assurances
periodically that the required level of
uncompensated care is being provided,
and that certain notification and
recordkeeping procedures are being
followed. These requirements are
referred to as the uncompensated
services assurance.
ESTIMATE OF INFORMATION COLLECTION BURDEN
Responses
per
respondent
No. of
respondents
Type of requirement and regulatory citation
Total
responses
Hours per
response
Total
hour burden
Disclosure burden (42 CFR)
Published Notices (124.504(c)) ...........................................
Individual Notices (124.504(c)) ............................................
Determinations of Eligibility (124.507) .................................
86
86
86
1
1
86
86
86
7,396
0.75
43.6
0.75
65
3,750
5,547
Subtotal Disclosure Burden ..........................................
........................
........................
........................
........................
9,362
10
1
10
11.0
110
4
0
2
1
........................
1
4
........................
2
6.0
........................
6.0
24
........................
12
37
4
0
1
1
1
37
14
0
0.5
0.5
0.5
18.5
7
0
10
10
1
1
10
10
0.25
0.5
3
5
........................
........................
........................
........................
179.5
Reporting
Uncompensated Services Report—HRSA–710 Form
(124.509(a)) ......................................................................
Application for Compliance Alternatives:
Public Facilities (124.513) ............................................
Small Obligation Facilities (124.514(c)) ........................
Charitable Facilities (124.516(c)) ..................................
Annual Certification for Compliance Alternatives:
Public Facilities (124.509(b)) ........................................
Charitable Facilities (124.509(b)) .................................
Small Obligation Facilities (124.509(c)) ........................
Complaint Information (124.511(a)):
Individuals .....................................................................
Facilities ........................................................................
mstockstill on PROD1PC66 with NOTICES
Subtotal Reporting Burden ....................................
Number of
recordkeepers
Recordkeeping
Hours per year
Total hour
burden
Non-alternative Facilities (124.510(a)) ..................................................................................
86
50
4,300
Subtotal Recordkeeping Burden .............................................................................
..........................
..........................
4,300
VerDate Nov<24>2008
19:02 Jan 15, 2009
Jkt 217001
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
E:\FR\FM\16JAN1.SGM
16JAN1
Agencies
[Federal Register Volume 74, Number 11 (Friday, January 16, 2009)]
[Notices]
[Pages 3060-3061]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-959]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2003-N-0103] (formerly Docket No. 2003N-0069)
Release of Task Force Report; Guidance for Industry and FDA:
Interim Evidence-Based Ranking System for Scientific Data; Withdrawal
of Guidance
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; withdrawal.
-----------------------------------------------------------------------
[[Page 3061]]
SUMMARY: The Food and Drug Administration (FDA) is announcing the
withdrawal of the guidance entitled ``Guidance for Industry and FDA:
Interim Evidence-Based Ranking System for Scientific Data'' that was
issued on July 10, 2003.
DATES: The withdrawal is effective January 16, 2009.
FOR FURTHER INFORMATION CONTACT: Paula R. Trumbo, Center for Food
Safety and Applied Nutrition (HFS-830), Food and Drug Administration,
5100 Paint Branch Pkwy., College Park, MD, 20740, 301-436-2579.
SUPPLEMENTARY INFORMATION: In a notice published in the Federal
Register of July 11, 2003 (68 FR 41387), FDA announced the availability
of a guidance entitled ``Guidance for Industry and FDA: Interim
Evidence-Based Ranking System for Scientific Data.'' This guidance is
being withdrawn because it is obsolete.
Dated: January 13, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E9-959 Filed 1-15-09; 8:45 am]
BILLING CODE 4160-01-S